Search

everythinglearnresearchcommunity

for

Search:↓

Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Vervet monkeys show physical changes like hair loss and scrotal color changes due to stress or nutrition issues.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

Young men with male pattern baldness lose hair density over time without treatment.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Nanoparticles can enter the skin, potentially causing toxicity, especially in damaged skin.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Improving the environment and cell interactions is key for creating human hair in the lab.

MicroRNAs are crucial for controlling skin development and healing by regulating genes.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Defective mitochondrial DNA replication causes aging symptoms and increased oxidative damage in mice.